Skip to nav Skip to content

218 Stories Found

How Interventional Radiology is Revolutionizing Cancer Diagnostics & Treatment

Moffitt is revolutionizing diagnostics & treatments with Interventional Radiology. IR gives patients expanded options that offer less pain and risk...

Using ctDNA Assay in Advanced Stages of Gastric and Esophageal Cancers to Predict Disease Progression

A study demonstrating use of ctDNA in predicting cancer progression in gastric and esophageal cancers presents beneficial outcomes.

Novel Immunotherapy Clinical Trials for Genitourinary Cancers

Immunotherapy clinical trials are continually bringing promising new treatments to patients with genitourinary cancer.

Tumor Infiltrating Lymphocyte Therapy for Solid Tumors

The potential impact TIL therapy can have on cancer patients is monumental, which is why Moffitt Cancer Center has been at the forefront of this...

Dr. Peter Forsyth in the lab

Innovative Dendritic Cell Vaccine Trial Provides Hope for Breast Cancer Patients with Leptomeningeal Disease

This novel therapy is designed to treat breast cancer patients whose tumor metastasizes to the brain and the spinal fluid.

Tumor Infiltrating Lymphocytes (TILs) Study for Patients with BCG Unresponsive High-Grade Non-Muscle Invasive Bladder Cancer

A clinical trial focuses on adoptive cellular therapy of tumor-infiltrating lymphocytes for BCG Unresponsive High-Grade Non-Muscle Invasive Bladder...

Moffitt Named a Comprehensive Radiopharmaceutical Therapy Center of Excellence by SNMMI

Moffitt is one of only 29 academic centers in the U.S. designated as a Comprehensive Radiopharmaceutical Therapy Center of Excellence.

Types of Sarcoma, a Deeper Look at a Few of the Subtypes

As a rule of thumb, any mass the size of a golf ball (>3cm) should be considered for a potential sarcoma diagnosis and referred to a specialist for...

Sarcoma Science Highlights

The Sarcoma Department at Moffitt is a multispecialty group focused on the treatment and cure of patients with all sarcoma subtype diagnoses

Moffitt's Gastrointestinal Team Completes its 100th Robotic Whipple Surgery

Moffitt's Gastrointestinal Program achieved its 100th robotic Whipple surgery, a highly complex surgical procedure to treat pancreatic cancer.

Tumor Infiltrating Lymphocytes (TILs) Clinical Trial Provides Hope for Recurrent or Metastatic Cervical Carcinoma Patients

Phase 2 study to evaluate the safety, tolerability and efficacy of cell transfer therapy using autologous tumor infiltrating lymphocytes (TIL) LN-145...

Q&A: Dr. Gustainyte Explains Uterine Fibroid Embolization Procedure in Patients with Uterine Fibroids

Moffitt physicians in the Department of Diagnostic Imaging and Interventional Radiology are highly specialized in performing uterine fibroid...

New Study on Management and Treatment of Vaginal Mucosal Melanoma

Moffitt researchers conduct an immune monitoring study to determine immunotherapy responses in vaginal mucosal melanoma patients.

Highlights of Moffitt Science Presented at Tandem Meetings of ASTCT and CIMBTR

Moffitt scientists are presenting advances in areas like cellular immunotherapy for relapsed or refractory (R/R) acute myeloid leukemia (AML),...

New Clinical Trial Aims to Genomically Personalize Radiation Therapy for Breast Cancer

Moffitt researchers are testing the feasibility of genomically guided radiation therapy to improve outcomes in triple-negative breast cancer patients...